Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
206.00    -4.00 (-1.90%)
Bid:
204.00
Ask:
205.00
Spread: 1.00 (0.49%)
Market Cap: £549.02m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

25 Apr 2024 11:41

RNS Number : 0633M
Costain Group PLC
25 April 2024
 

 

 

Costain Group PLC (the 'Company')

25 April 2024

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the final dividend for the year ended 31 December 2023 is 79.08 pence per ordinary share.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 18 April 2024.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the final dividend for the year ended 31 December 2023 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 3 May 2024.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The final dividend for the year ended 31 December 2023, including the scrip dividend, will be paid on 28 May 2024 (the dividend payment date), subject to approval at the 2024 Annual General Meeting on 16 May 2024, to the ordinary shareholders of the Company on the register at close of business on 19 April 2024 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

Investors and analysts

Paul Sharma, Costain

paul.sharma@costain.com

+44 (0) 7867 501188

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997 365

Charlie Twigg

+44 (0) 7946 494 568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPURWCUPCGUA
Date   Source Headline
23rd Jul 202511:03 amRNSHolding(s) in Company
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 202510:41 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20255:04 pmRNSHolding(s) in Company
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20259:13 amRNSHolding(s) in Company
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:09 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20259:51 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20254:14 pmRNSHolding(s) in Company
8th Jul 20259:24 amRNSHolding(s) in Company
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 202512:35 pmRNSHolding(s) in Company
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 202511:12 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20253:48 pmRNSHolding(s) in Company
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20253:38 pmRNSTotal Voting Rights - Correction
2nd Jul 20258:37 amRNSBlock listing Interim Review
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20252:33 pmRNSTotal Voting Rights
1st Jul 202512:29 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20252:17 pmRNSHolding(s) in Company
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20252:48 pmRNSHolding(s) in Company
25th Jun 202511:55 amRNSDIRECTOR/PDMR/PCA DEALING
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20253:37 pmRNSHolding(s) in Company
16th Jun 20257:00 amRNS£10m Share Buyback Programme & H1 Trading Update
9th Jun 20253:38 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNSHeathrow Site Visit
4th Jun 202512:17 pmRNS-RCostain awarded Anglian Water contract extension
4th Jun 202511:50 amRNSHolding(s) in Company
2nd Jun 20254:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.